Mini-review: Antibody-PET of receptor tyrosine kinase interplay and heterogeneity

Anusha Chegu1, Sandeep Surendra Panikar2, Patricia M R Pereira2

  • 1Department of Radiology, Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, MO 63110, United States of America; Department of Biology, Washington University School of Medicine, St. Louis, MO 63130-4899, United States of America.

Insights

Receptor tyrosine kinase (RTK)-targeted therapies are limited by tumor resistance. RTK-targeted PET imaging offers real-time, whole-body insights into RTK heterogeneity and co-activation, aiding cancer management and recurrence detection.

Area of Science:

  • Oncology
  • Radiochemistry
  • Molecular Imaging

Background:

  • Targeted therapies for receptor tyrosine kinases (RTKs) show variable efficacy due to tumor heterogeneity and co-activation.
  • Non-invasive positron emission tomography (PET) combined with RTK-specific antibodies allows real-time, in-vivo study of cancer biology.
  • RTK-targeted antibody-PET imaging conjugates are emerging tools for oncology patient management.

Purpose of the Study:

  • To review clinical and preclinical data on RTK-targeted PET imaging.
  • To focus on detecting RTK heterogeneity and co-activation as mechanisms of tumor resistance.
  • To provide an overview of recent RTK-targeted PET imaging studies.

Main Methods:

  • Review of clinical and preclinical studies published within the last 4 years.
  • Focus on studies utilizing RTK-specific antibody-PET imaging conjugates.
  • Analysis of data related to RTK heterogeneity and co-activation in tumors.

Main Results:

  • RTK-targeted PET imaging can visualize RTK heterogeneity and co-activation in real-time.
  • This imaging modality shows potential for early cancer diagnosis and treatment response assessment.
  • Studies demonstrate the utility of RTK-targeted PET in understanding tumor resistance mechanisms.

Conclusions:

  • RTK-targeted PET imaging is a valuable tool for assessing tumor resistance mechanisms like RTK heterogeneity and co-activation.
  • This technique aids in prognostic information and imaging disease recurrence.
  • RTK-targeted antibody-PET conjugates hold significant promise for personalized oncology.

Related Concept Videos

Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
14.7K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.6K
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
3.0K
Diversity of Antigen Receptors01:28

Diversity of Antigen Receptors

Antigen receptors are essential components of the immune system crucial in defending the body against foreign invaders. These receptors are present on the surface of B and T cells, enabling them to recognize antigens and mount an appropriate immune response.
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
849
Enzyme-linked Receptors01:00

Enzyme-linked Receptors

Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
80.3K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.2K